Yesil Science / Blog

Blog

Every article we have published: research summaries, product thinking and developments in health AI.

3,627articles so far

Latest articles

Health Economics

UK to accept US medical device approvals

The UK is abandoning regulatory isolationism to keep its healthcare system from falling behind.

Epidemiology

Gut bacteria predict hospital stays for cirrhosis patients

Analyzing the gut microbiome could prevent costly hospitalizations for patients with advanced liver disease.

Drug Discovery

Nvidia-Backed Iambic Therapeutics Files For IPO

An AI-native biotech is testing public market appetite, signaling a shift from tech hype to clinical execution.

LLM's

Top Performing AI Fails Clinical Reality Check

A new study reveals that training AI to ace medical benchmarks actually makes its clinical reasoning worse, exposing a dangerous gap in...

LLM's

Why Chatbot Diagnosis Is Still Highly Risky

Patients who swap doctors for chatbots are playing a dangerous game of probability with their health.

LLM's

Fully Automated Abstraction of Longitudinal Breast Oncology Records with Off-The-Shelf Large Language Models

Off-the-shelf artificial intelligence can now parse thousands of pages of messy medical records to build research-grade cancer datasets, matching the accuracy of...

AI in Pulmonology

The Pulmonology AI Report — September 2026

Imaging-based development and validation of artificial intelligence models for lung adenocarcinoma precursor lesions and early lung adenocarcinoma presenting as pulmonary nodules

Hospital Management

How AI Solves the EHR Documentation Bottleneck

Doctors spend hours typing notes after their shifts end, but automating real-time chart completion could finally end the pajama-time documentation crisis.

Endocrinology

AI finds which kidney patients need SGLT2 inhibitors

A new causal machine learning analysis reveals that standard population-level prescribing guidelines for diabetic kidney disease are masking critical, individual-level treatment failures.

Drug Discovery

AbbVie Bets on Iambic’s New AI Model

Big Pharma is no longer just experimenting with AI; it is embedding massive neural networks directly into the core of drug discovery.

Cardiology

AI ECG predicts genetic heart disease risk

A new study shows artificial intelligence can read standard electrocardiograms to spot a deadly genetic heart condition before traditional symptoms appear.

LLM's

AI Solves the Clinical Trial Data Bottleneck

Clinical trials are stalling under the weight of unstructured data, but AI is shifting from an experimental tool to an operational necessity.